NRG Oncology
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 2014-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.nrgoncology.org
Comparing High-Dose Cisplatin Every Three Weeks to Low-Dose Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer
- Conditions
- Interventions
- First Posted Date
- 2021-09-20
- Last Posted Date
- 2024-11-29
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 464
- Registration Number
- NCT05050162
- Locations
- ๐บ๐ธ
UC Irvine Health Cancer Center-Newport, Costa Mesa, California, United States
๐บ๐ธUCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States
๐บ๐ธMercy Cancer Center - Carmichael, Carmichael, California, United States
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score
- First Posted Date
- 2021-09-20
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 2050
- Registration Number
- NCT05050084
- Locations
- ๐บ๐ธ
Arizona Center for Cancer Care - Gilbert, Gilbert, Arizona, United States
๐บ๐ธArizona Center for Cancer Care-Peoria, Peoria, Arizona, United States
๐บ๐ธArizona Center for Cancer Care - Phoenix, Phoenix, Arizona, United States
Testing the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2021-05-10
- Last Posted Date
- 2024-01-10
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 144
- Registration Number
- NCT04878952
- Locations
- ๐บ๐ธ
WellSpan Health - Ephrata, Ephrata, Pennsylvania, United States
๐บ๐ธWellSpan Health - Chambersburg, Chambersburg, Pennsylvania, United States
๐บ๐ธWellSpan Health - Gettysburg, Gettysburg, Pennsylvania, United States
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- First Posted Date
- 2021-04-21
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 1670
- Registration Number
- NCT04852887
- Locations
- ๐บ๐ธ
Kaiser Permanente-Riverside, Riverside, California, United States
๐บ๐ธLutheran Hospital - Cancer Centers of Colorado, Golden, Colorado, United States
๐บ๐ธHealth Central, Ocoee, Florida, United States
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
- Conditions
- Interventions
- First Posted Date
- 2021-03-18
- Last Posted Date
- 2024-11-29
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 200
- Registration Number
- NCT04804644
- Locations
- ๐บ๐ธ
Kaiser Permanente-Anaheim, Anaheim, California, United States
๐บ๐ธKaiser Permanente-Bellflower, Bellflower, California, United States
๐บ๐ธKaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States
Testing the Addition of Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in People With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
- Conditions
- Metastatic MelanomaPrognostic Stage IV Breast Cancer AJCC v8Metastatic Digestive System CarcinomaStage IV Renal Cell Cancer AJCC v8Stage IVA Lung Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Malignant Neoplasm in the BrainStage IVB Lung Cancer AJCC v8Metastatic Lung Non-Small Cell Carcinoma
- Interventions
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2024-01-10
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 350
- Registration Number
- NCT04588246
- Locations
- ๐บ๐ธ
Banner University Medical Center - Tucson, Tucson, Arizona, United States
๐บ๐ธUniversity of Arizona Cancer Center-North Campus, Tucson, Arizona, United States
๐บ๐ธCity of Hope Corona, Corona, California, United States
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
- Conditions
- Interventions
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 2478
- Registration Number
- NCT04513717
- Locations
- ๐บ๐ธ
Arizona Center for Cancer Care - Gilbert, Gilbert, Arizona, United States
๐บ๐ธArizona Center for Cancer Care - Phoenix, Phoenix, Arizona, United States
๐บ๐ธArizona Center for Cancer Care - Scottsdale, Scottsdale, Arizona, United States
Testing the Addition of the Anti-cancer Viral Therapy Telomelysinโข to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery
- Conditions
- Advanced Gastroesophageal Junction AdenocarcinomaPathologic Stage II Esophageal Adenocarcinoma AJCC v8Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8Advanced Esophageal AdenocarcinomaClinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage III Esophageal Adenocarcinoma AJCC v8
- Interventions
- First Posted Date
- 2020-05-18
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 16
- Registration Number
- NCT04391049
- Locations
- ๐บ๐ธ
City of Hope Comprehensive Cancer Center, Duarte, California, United States
๐บ๐ธMoffitt Cancer Center, Tampa, Florida, United States
๐บ๐ธCity of Hope South Pasadena, South Pasadena, California, United States
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- Conditions
- Hard Palate Squamous Cell CarcinomaLip Squamous Cell CarcinomaStage I Lip and Oral Cavity Cancer AJCC v8Tongue Squamous Cell CarcinomaLower Alveolar Ridge Squamous Cell CarcinomaRetromolar Trigone Squamous Cell CarcinomaStage II Lip and Oral Cavity Cancer AJCC v8Buccal Mucosa Squamous Cell CarcinomaFloor of Mouth Squamous Cell CarcinomaGingival Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2020-04-03
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 618
- Registration Number
- NCT04333537
- Locations
- ๐บ๐ธ
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
๐บ๐ธBanner MD Anderson Cancer Center, Gilbert, Arizona, United States
๐บ๐ธMayo Clinic Hospital in Arizona, Phoenix, Arizona, United States
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Conditions
- Interventions
- First Posted Date
- 2020-01-31
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 2262
- Registration Number
- NCT04251052
- Locations
- ๐บ๐ธ
Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
๐บ๐ธAnchorage Radiation Therapy Center, Anchorage, Alaska, United States
๐บ๐ธAlaska Breast Care and Surgery LLC, Anchorage, Alaska, United States